Market Overview:
The global atherectomy devices market is expected to grow from USD 1.5 billion in 2018 to USD 3.2 billion by 2030, at a CAGR of 10.8% during the forecast period. The growth of this market can be attributed to the increasing incidence of cardiovascular diseases and peripheral vascular diseases, growing demand for minimally invasive procedures, and rising geriatric population. However, the high cost of devices and limited reimbursement policies are restraining the growth of this market. Based on type, the global atherectomy devices market is segmented into directional atherectomy, rotational atherectomy, orbital atherectomy, and laser atherectomy. The directional atherectomy segment is expected to account for the largest share of the global atherectomy devices market in 2018.
Product Definition:
Athrectomy Devices are used to remove atherosclerotic plaque from an artery. The devices include atherectomy tools, such as rotating or reciprocating wire brushes, lasers, and high-pressure water jets; atherectomy balloons; and stent retrievers.
Directional Atherectomy:
Directional atherectomy is a minimally invasive procedure used to remove part of the blood clot from the blocked artery. It is one of the most popular minimally invasive procedures for treating coronary artery disease and peripheral artery disease. The directional atherectomy devices market growth factor includes factors such as rising prevalence of atherosclerosis, growing geriatric population base, increasing healthcare awareness among people and government initiatives to provide easy access to treatment in emerging economies like India & China.
Rotational Atherectomy:
Rotational atherectomy is a minimally invasive procedure used to remove plaque from the inside of an artery. It uses suction and centrifugal force to clear the blockage in arteries. The technique was first introduced by Dr. Robert Langer in 1990 as a method for removing atherosclerotic plaque from carotid arteries, hence it is also known as carotid rotational atherectomy (CRAT).
Application Insights:
The cardiovascular segment dominated the market in 2017 and is expected to maintain its lead over the forecast period. This can be attributed to an increase in cardiovascular diseases, which are a major cause of death globally. According to WHO, around 17 million people die from Cardiovascular Diseases (CVDs) every year. Increasing geriatric population and unhealthy lifestyle habits such as lack of exercise & proper nutrition are among major factors contributing towards increasing CVDs across the globe.
According to data published by International Society on Thrombosis and Haemostasis, Inc., it was estimated that around 446 million individuals were affected by venous thromboembolism (VTE) worldwide in 2015; out of which approximately 149 million were diagnosed with VTE as primary diagnosis while another 142 million had associated VTE as secondary diagnosis.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of diabetes and obesity. According to CDC, around 29.1 million people were diagnosed with diabetes in 2015 while another 86.6 million were estimated to have been affected but undiagnosed as of yet.
In Asia Pacific, rotational.
The key players operating in this region are Olympus Corporation; Fujifilm Wako Pure Chemical Corp.; Koninklijke Philips N.V.; Samsung Medical Center Co., Ltd.
Growth Factors:
- Increasing incidence of arthritis and other orthopedic diseases: The global prevalence of arthritis is expected to increase from 350 million in 2010 to nearly 550 million by 2030. This will drive the demand for athrectomy devices as they are used for the treatment of various orthopedic diseases.
- Technological advancements: The development of new and innovative athrectomy devices has helped to improve the accuracy and efficacy of these devices, thus driving their demand. For instance, the introduction of laser-assisted arthroscopy has helped reduce tissue damage and improve patient outcomes.
- Rising geriatric population: The global geriatric population is expected to grow at a rapid pace in the coming years, which will lead to an increase in the number of patients suffering from age-related orthopedic conditions such as arthritis. This will create a high demand for athrectomy devices as they are used for treating such conditions.
Scope Of The Report
Report Attributes
Report Details
Report Title
Athrectomy Devices Market Research Report
By Type
Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy
By Application
Cardiovascular, Peripheral, Neurovascular
By Companies
Boston Scientific, Cardiovascular Systems, Medtronic, Spectranetics, VOLCANO, Avinger, Bayer, Straub Medical, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), Terumo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Athrectomy Devices Market Report Segments:
The global Athrectomy Devices market is segmented on the basis of:
Types
Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Peripheral, Neurovascular
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Cardiovascular Systems
- Medtronic
- Spectranetics
- VOLCANO
- Avinger
- Bayer
- Straub Medical
- ST. JUDE MEDICAL
- BARD Peripheral Vascular
- Cardinal Health (Cordis)
- Terumo
Highlights of The Athrectomy Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Directional Atherectomy
- Rotational Atherectomy
- Orbital Atherectomy
- Laser Atherectomy
- By Application:
- Cardiovascular
- Peripheral
- Neurovascular
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Athrectomy Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Athrectomy devices are surgical tools that are used to remove the prostate.
Some of the major players in the athrectomy devices market are Boston Scientific, Cardiovascular Systems, Medtronic, Spectranetics, VOLCANO, Avinger, Bayer, Straub Medical, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), Terumo.
The athrectomy devices market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Athrectomy Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Athrectomy Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Athrectomy Devices Market - Supply Chain
4.5. Global Athrectomy Devices Market Forecast
4.5.1. Athrectomy Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Athrectomy Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Athrectomy Devices Market Absolute $ Opportunity
5. Global Athrectomy Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Athrectomy Devices Market Size and Volume Forecast by Type
5.3.1. Directional Atherectomy
5.3.2. Rotational Atherectomy
5.3.3. Orbital Atherectomy
5.3.4. Laser Atherectomy
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Athrectomy Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Athrectomy Devices Market Size and Volume Forecast by Application
6.3.1. Cardiovascular
6.3.2. Peripheral
6.3.3. Neurovascular
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Athrectomy Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Athrectomy Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Athrectomy Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Athrectomy Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Athrectomy Devices Demand Share Forecast, 2019-2029
9. North America Athrectomy Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Athrectomy Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Athrectomy Devices Market Size and Volume Forecast by Application
9.4.1. Cardiovascular
9.4.2. Peripheral
9.4.3. Neurovascular
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Athrectomy Devices Market Size and Volume Forecast by Type
9.7.1. Directional Atherectomy
9.7.2. Rotational Atherectomy
9.7.3. Orbital Atherectomy
9.7.4. Laser Atherectomy
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Athrectomy Devices Demand Share Forecast, 2019-2029
10. Latin America Athrectomy Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Athrectomy Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Athrectomy Devices Market Size and Volume Forecast by Application
10.4.1. Cardiovascular
10.4.2. Peripheral
10.4.3. Neurovascular
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Athrectomy Devices Market Size and Volume Forecast by Type
10.7.1. Directional Atherectomy
10.7.2. Rotational Atherectomy
10.7.3. Orbital Atherectomy
10.7.4. Laser Atherectomy
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Athrectomy Devices Demand Share Forecast, 2019-2029
11. Europe Athrectomy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Athrectomy Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Athrectomy Devices Market Size and Volume Forecast by Application
11.4.1. Cardiovascular
11.4.2. Peripheral
11.4.3. Neurovascular
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Athrectomy Devices Market Size and Volume Forecast by Type
11.7.1. Directional Atherectomy
11.7.2. Rotational Atherectomy
11.7.3. Orbital Atherectomy
11.7.4. Laser Atherectomy
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Athrectomy Devices Demand Share, 2019-2029
12. Asia Pacific Athrectomy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Athrectomy Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Athrectomy Devices Market Size and Volume Forecast by Application
12.4.1. Cardiovascular
12.4.2. Peripheral
12.4.3. Neurovascular
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Athrectomy Devices Market Size and Volume Forecast by Type
12.7.1. Directional Atherectomy
12.7.2. Rotational Atherectomy
12.7.3. Orbital Atherectomy
12.7.4. Laser Atherectomy
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Athrectomy Devices Demand Share, 2019-2029
13. Middle East & Africa Athrectomy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Athrectomy Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Athrectomy Devices Market Size and Volume Forecast by Application
13.4.1. Cardiovascular
13.4.2. Peripheral
13.4.3. Neurovascular
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Athrectomy Devices Market Size and Volume Forecast by Type
13.7.1. Directional Atherectomy
13.7.2. Rotational Atherectomy
13.7.3. Orbital Atherectomy
13.7.4. Laser Atherectomy
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Athrectomy Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Athrectomy Devices Market: Market Share Analysis
14.2. Athrectomy Devices Distributors and Customers
14.3. Athrectomy Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boston Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cardiovascular Systems
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Spectranetics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. VOLCANO
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Avinger
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bayer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Straub Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ST. JUDE MEDICAL
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. BARD Peripheral Vascular
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cardinal Health (Cordis)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Terumo
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
